R.-P. Perng

1.2k total citations
47 papers, 950 citations indexed

About

R.-P. Perng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, R.-P. Perng has authored 47 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 13 papers in Surgery. Recurrent topics in R.-P. Perng's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Diagnosis and Treatment (7 papers). R.-P. Perng is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Diagnosis and Treatment (7 papers). R.-P. Perng collaborates with scholars based in Taiwan, United States and France. R.-P. Perng's co-authors include Chun‐Ming Tsai, Adi F. Gazdar, Tetsuya Mitsudomi, Jacqueline Whang‐Peng, Yan-Ming Chen, C.-M. Tsai, Li‐Hwa Wu, Chikabumi Kadoyama, Mien‐Chie Hung and Chih–Chien Tsai and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

R.-P. Perng

44 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.-P. Perng Taiwan 18 535 440 318 165 139 47 950
Munehisa Imaizumi Japan 17 380 0.7× 458 1.0× 247 0.8× 164 1.0× 67 0.5× 41 968
Donnah Jones United States 12 280 0.5× 221 0.5× 166 0.5× 112 0.7× 87 0.6× 14 740
A M Ballesta Spain 17 508 0.9× 136 0.3× 351 1.1× 171 1.0× 149 1.1× 32 930
Hitoshi Kotanagi Japan 18 335 0.6× 189 0.4× 171 0.5× 377 2.3× 149 1.1× 73 875
Sandra J. Casak United States 18 455 0.9× 215 0.5× 171 0.5× 189 1.1× 84 0.6× 32 1.0k
Ettore D’Argento Italy 18 538 1.0× 382 0.9× 218 0.7× 105 0.6× 51 0.4× 52 890
Qiuhua Deng China 14 389 0.7× 552 1.3× 352 1.1× 170 1.0× 111 0.8× 38 1.1k
Ashok K. Vaid India 15 781 1.5× 455 1.0× 188 0.6× 65 0.4× 193 1.4× 54 1.1k
Steven Blotner United States 17 598 1.1× 223 0.5× 257 0.8× 125 0.8× 80 0.6× 36 1.1k
H. J. Illiger Germany 11 555 1.0× 266 0.6× 386 1.2× 121 0.7× 39 0.3× 28 974

Countries citing papers authored by R.-P. Perng

Since Specialization
Citations

This map shows the geographic impact of R.-P. Perng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.-P. Perng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.-P. Perng more than expected).

Fields of papers citing papers by R.-P. Perng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.-P. Perng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.-P. Perng. The network helps show where R.-P. Perng may publish in the future.

Co-authorship network of co-authors of R.-P. Perng

This figure shows the co-authorship network connecting the top 25 collaborators of R.-P. Perng. A scholar is included among the top collaborators of R.-P. Perng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.-P. Perng. R.-P. Perng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, En‐Ting, et al.. (2009). Septic pulmonary embolism associated with a peri-proctal abscess in an immunocompetent host. BMJ Case Reports. 2009. bcr0720080592–bcr0720080592. 3 indexed citations
2.
3.
4.
5.
Letts, M, et al.. (2000). An analysis of a preoperative pediatric autologous blood donation program.. PubMed. 43(2). 125–9. 10 indexed citations
6.
Perng, R.-P., et al.. (2000). A Phase II Trial of Tamoxifen, Ifosfamide, Epirubicin, and Cisplatin Combination Chemotherapy for Inoperable Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 23(1). 13–17. 13 indexed citations
7.
Chen, Yaow-Ming, et al.. (1999). Disconnection of a Venous Port-A-Cath Followed by Embolization After Saline Flush: Rare Case Report. Japanese Journal of Clinical Oncology. 29(12). 643–645. 10 indexed citations
8.
Liu, Jacqueline Ming, Ming‐Fang Wu, Wei-Chun Lin, et al.. (1998). Ifosfamide-based chemotherapy for previously treated lung cancer patients.. PubMed. 61(7). 389–96. 1 indexed citations
9.
Wu, Ming‐Fang, R.-P. Perng, Wen‐chang Lin, et al.. (1997). Phase II Study of Ifosfamide and Etoposide Chemotherapy for Extensive-Disease Small-Cell Lung Cancer. Japanese Journal of Clinical Oncology. 27(2). 76–79. 3 indexed citations
10.
Tsai, Chun‐Ming, et al.. (1996). Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.. PubMed. 56(5). 1068–74. 74 indexed citations
11.
Chung, Chi‐Li & R.-P. Perng. (1996). Thymic cyst: a case report. Clinical Medicine. 37. 63–64.
12.
Chen, Yin‐Quan, et al.. (1996). Shortened Survival of Lung Cancer Patients Initially Presenting with Pulmonary Tuberculosis. Japanese Journal of Clinical Oncology. 26(5). 322–327. 30 indexed citations
13.
Shih, Jen-Fu, et al.. (1996). Tuberculous subcutaneous abscess: An analysis of seven cases. Tubercle and Lung Disease. 77(2). 184–187. 40 indexed citations
14.
Perng, Diahn-Warng, et al.. (1996). The Variation of Cell Type Distribution in Lung Cancer: A Study of 10,910 Cases at a Medical Center in Taiwan between 1970 and 1993. Japanese Journal of Clinical Oncology. 26(4). 229–233. 21 indexed citations
15.
Chen, Yan-Ming, et al.. (1996). Serum Cytokine Level Fluctuations in Chemotherapy-induced Myelosuppression. Japanese Journal of Clinical Oncology. 26(1). 18–23. 34 indexed citations
16.
17.
Tsai, Chih–Chien, et al.. (1995). Enhanced Chemoresistance by Elevation of p185neu Levels in HER-2/neu-Transfected Human Lung Cancer Cells. JNCI Journal of the National Cancer Institute. 87(9). 682–684. 78 indexed citations
18.
Tsai, Chih–Chien, et al.. (1994). Greater Enhancement of Chemosensitivity by Caffeine in High-p185neu-Expressing Human Non-Small-Cell Lung Cancer Cell Lines. JNCI Journal of the National Cancer Institute. 86(13). 1018–1020. 10 indexed citations
19.
Tsai, Chun‐Ming, et al.. (1993). Correlation of Intrinsic Chemoresistance of Non-Small-Cell Lung Cancer Cell Lines With HER-2/neu Gene Expression but Not With ras Gene Mutations. JNCI Journal of the National Cancer Institute. 85(11). 897–901. 142 indexed citations
20.
Wang, Li‐Shun, et al.. (1988). [Pulmonary cryptococcosis with spontaneous resolution--although with high serum cryptococcal antigen titer].. PubMed. 41(5). 379–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Munehisa Imaizumi Breakdown of academic impact, for papers by Donnah Jones Breakdown of academic impact, for papers by A M Ballesta Breakdown of academic impact, for papers by Hitoshi Kotanagi Breakdown of academic impact, for papers by Sandra J. Casak Breakdown of academic impact, for papers by Ettore D’Argento Breakdown of academic impact, for papers by Qiuhua Deng Breakdown of academic impact, for papers by Ashok K. Vaid Breakdown of academic impact, for papers by Steven Blotner Breakdown of academic impact, for papers by H. J. Illiger
Rankless by CCL
2026